| n | % | Observed deaths | Crude mortality rate % | p-value (log-rank test) |
---|---|---|---|---|---|
Recipient age | Â | Â | Â | Â | Â |
 18-29 | 997 | 8.1 | 43 | 4.3 | <0.001* |
 30-39 | 2034 | 16.5 | 115 | 5.7 |  |
 40-49 | 3185 | 25.9 | 256 | 8.0 |  |
 50-59 | 3110 | 25.3 | 407 | 13.1 |  |
  > 60 | 2981 | 24.2 | 682 | 22.9 |  |
Recipient gender | Â | Â | Â | Â | Â |
 Male | 7628 | 62.0 | 984 | 12.9 | 0.002 |
 Female | 4673 | 38.0 | 517 | 11.1 |  |
 Not reported | 6 | 0.1 | - | - |  |
Recipient ethnicity | Â | Â | Â | Â | Â |
 White | 9871 | 80.2 | 1248 | 12.6 | 0.033 |
 Asian | 1376 | 11.2 | 164 | 11.9 |  |
 Other | 1049 | 8.5 | 90 | 8.6 |  |
 Not reported | 11 | 0.1 | - | - |  |
Transplanted organs | Â | Â | Â | Â | Â |
 Kidney only | 11013 | 89.5 | 1368 | 12.4 | 0.253 |
 Kidney and pancreas | 1294 | 10.5 | 135 | 10.4 |  |
Pre-emptive transplant | Â | Â | Â | Â | Â |
 No | 11019 | 89.5 | 1406 | 12.8 | <0.001 |
 Yes | 1270 | 10.3 | 92 | 7.2 |  |
 Not reported | 18 | 0.2 | - | - |  |
cRF | Â | Â | Â | Â | Â |
 0-9 % | 10026 | 81.5 | 1229 | 12.3 | 0.356 |
 10-29 % | 523 | 4.3 | 55 | 10.5 |  |
 30-84 % | 1357 | 11.0 | 171 | 12.6 |  |
 85-100 % | 401 | 3.3 | 48 | 12.0 |  |
Waiting time | Â | Â | Â | Â | Â |
 < 6 months | 1941 | 15.8 | 243 | 12.5 | 0.003* |
 6 months to <2 years | 4129 | 33.6 | 538 | 13.0 |  |
 > 2 years | 6237 | 50.7 | 722 | 11.6 |  |
Primary renal disease | Â | Â | Â | Â | Â |
 Glomerulonephritis | 1849 | 15.0 | 186 | 10.1 | <0.001 |
 Diabetic nephropathy (type 1) | 1705 | 13.9 | 230 | 13.5 |  |
 Diabetic nephropathy (type 2) | 380 | 3.1 | 71 | 18.7 |  |
 Renal vascular disease | 545 | 4.4 | 78 | 14.3 |  |
 Polycystic kidney disease | 1513 | 12.3 | 147 | 9.7 |  |
 Pyelonephritis | 804 | 6.5 | 95 | 11.8 |  |
 Other | 1573 | 12.8 | 181 | 11.5 |  |
 Not reported | 3938 | 32.0 | 515 | 13.1 |  |
Donor age | Â | Â | Â | Â | Â |
 < 40 | 3650 | 29.7 | 306 | 8.4 | <0.001* |
 40-49 | 2754 | 22.4 | 324 | 11.8 |  |
 50-59 | 3200 | 26.0 | 416 | 13.0 |  |
 > 60 | 2703 | 22.0 | 457 | 16.9 |  |
Donor type | Â | Â | Â | Â | Â |
 Brain-death donor | 8812 | 71.6 | 1117 | 12.7 | 0.003 |
 Circulatory-death donor | 3495 | 28.4 | 386 | 11.0 |  |
Donor hypertension | Â | Â | Â | Â | Â |
 No | 8688 | 70.6 | 938 | 10.8 | <0.001 |
 Yes | 2525 | 20.5 | 386 | 15.3 |  |
 Not reported | 1094 | 8.9 | 179 | 16.4 |  |
Donor diabetes | Â | Â | Â | Â | Â |
 Negative | 10790 | 87.7 | 1268 | 11.8 | 0.021 |
 Positive | 541 | 4.4 | 69 | 12.8 |  |
 Not reported | 976 | 7.9 | 166 | 17.0 |  |
Donor weight | Â | Â | Â | Â | Â |
 < 55 kg | 3150 | 25.6 | 380 | 12.1 | 0.036 |
 55-65 kg | 723 | 5.9 | 62 | 8.6 |  |
 65-75 kg | 1721 | 14.0 | 215 | 12.5 |  |
 75-85 kg | 3234 | 26.3 | 411 | 12.7 |  |
 85-95 kg | 1973 | 16.0 | 226 | 11.5 |  |
 > 95 kg | 1342 | 10.9 | 168 | 12.5 |  |
 Not reported | 164 | 1.3 | - | - |  |
Donor cause of death | Â | Â | Â | Â | Â |
 Trauma | 1510 | 12.3 | 158 | 10.5 | <0.001 |
 Intracranial | 7954 | 64.6 | 1059 | 13.3 |  |
 Other | 2843 | 23.1 | 286 | 10.1 |  |
HLA mismatch | Â | Â | Â | Â | Â |
 Level 1 [000] | 1485 | 12.1 | 193 | 13.0 | 0.001* |
 Level 2 [0 DR + 0/1 B] | 4002 | 32.5 | 467 | 11.7 |  |
 Level 3 [0 DR + 2 B] or [1 DR + 0/1 B] | 5192 | 42.2 | 624 | 12.0 |  |
 Level 4 [1 DR + 2 B] or [2 DR] | 1628 | 13.2 | 219 | 13.5 |  |
Cold ischaemia time | Â | Â | Â | Â | Â |
  < 12 hrs | 2061 | 16.8 | 177 | 8.6 | 0.310* |
 12 to <18 hrs | 5859 | 47.6 | 691 | 11.8 |  |
 18 to <24 hrs | 2930 | 23.8 | 427 | 14.6 |  |
 > = 24 hrs | 1264 | 10.3 | 186 | 14.7 |  |
 Not reported | 193 | 1.6 | - | - |  |